ARTV filings
Corporate insider profile
Fred Aslan Filing Activity
Latest reported as Chief Executive Officer of Artiva Biotherapeutics, Inc. (ARTV).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$244,252.79
- Latest transaction
- May 19, 2026
Affiliated corporations
Reported company relationships
Transaction history
